Newlyweds Among Thousands to Walk for Research at UC Brain Tumor Center
CINCINNATI—People diagnosed with a brain tumor cannot only survive, but they can also live happily ever after. At 8 a.m. Sunday, Oct. 23, at Sawyer Point, Walk Ahead for a Brain Tumor Cure will celebrate two young brain tumor survivors who found their perfect match and were married during the last year:
- Survivor Collin June, patient relations supervisor at the University of Cincinnati Medical Center, and his wife, Rachel June, MD.
- Survivor Leslie Sommer, a fifth grade teacher and assistant women's soccer coach at Wittenberg University, and her husband, Roland Sommer.
The Junes and Sommers will enjoy a piece of post-wedding cake and then join more than 3,000 walkers and runners in the seventh annual event.
Since its founding in 2010, the 5k walk/run has raised more than $1.5 million for research and education at the Brain Tumor Center at the University of Cincinnati (UC) Gardner Neuroscience Institute and the UC Cancer Institute. The institutes are collaborations of the UC College of Medicine and UC Health.
An estimated 240,000 brain tumors are diagnosed in the United States each year; of these, 70,000 have originated in the brain and 170,000 have metastasized from other parts of the body.
Patients, physicians and researchers of the UC Brain Tumor Center will be available for interviews before, during and after the Oct. 23 event.
Walk Ahead 5k Schedule
7:30 a.m.: Same-day registration opens
8:30 a.m.: Shotgun start for chip-timed 5K run, beginning at Yeatman's Cove, Sawyer Point
9:00 a.m.: Shotgun start for 5k walk, beginning at Yeatman's Cove, Sawyer Point
More information:
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.